CGTX
Cognition Therapeutics IncCompany with tickers: CGTX
CIK
1455365
CUSIP
19243B102
Shares Outstanding
89,498,015
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $13,775,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Research & Development | $10,786,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Operating Income | $-13,775,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Net Income | $-8,480,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| EPS (Basic) | $-0.14 | USD/shares | 2025-03-31 | 10-Q | 2026-05-08 |
| EPS (Diluted) | $-0.14 | USD/shares | 2025-03-31 | 10-Q | 2026-05-08 |